

NGS Characterized Biospecimens
Precision for Medicine’s NGS-characterized biospecimens library

Library details
13K+ Biospecimens
23 Oncology indications
Sequenced via :
-
Oncomine precision assay
-
truSighttm oncology 500 assay

Biospecimen types
FFPE blocks: Tumor, normal, and adjacent tissue
H&E images for every biospecimen
Isolated DNA/RNA for most samples
Available data
-
Characterization Data
-
Surgical Pathology Report
-
Histologic Subtype
-
Grade/Stage
-
Demographics
Total specimen counts

Details of Precision’s library of two NGS-characterized biospecimen indications: variant data for lung cancer and colorectal cancer biospecimens
Lung Cancer Biospecimens by Variant

Colorectal Cancer Biospecimens by Variant
.png?width=761&name=Chart%202%20(1).png)
Deeper dive Into lung cancer characterization data
Lung Cancer Biospecimens by Cancer Subtype

Colorectal Cancer Biospecimens by Variant

NGS-characterized biospecimens and data available:
1. FFPE Tissue Slides


2. Characterization Data
Below is a table showing examples of some of the data available. Additional (not shown) data include: Surgical procedure, Stage, Demographics, % Tumor, % Necrosis, NGS assay

3. H&E Images

4. DNA/RNA

Additional methods available to analyze and characterize biospecimens
In addition to a selection of high-quality characterized biospecimens, Precision provides specialty lab services to assess these biospecimens using several technologies, including:
-
IHC and mIF
- Leica BOND
- Dako Omnis, Dako Link 48, Artisan
- Ventana BenchMark
- Akoya Phenolmager™ HT
- Pathology Services
-
Digital pathology and slide scanning
- Proscia Concentriq®
- Aperio GT 450
- Aperio AT2
- 3DHISTECH
-
NGS and Genomics
- NGS: multiple platforms
- NanoString
- ddPCR, qPCR
- 10x genomics
Learn more about the uses of characterized biospecimens
Characterized Biospecimens: A Guide for Leveraging Deeply Characterized Biospecimens
Download Whitepaper

Precision’s tissue biospecimen biorepository
Precision’s tissue biorepository contains >3 million FFPE samples and several million histology slides covering a full spectrum of oncologic and medical diseases
Precision’s NGS characterization panels
Precision uses the TruSight™ Oncology 500 (TSO 500) panel and the Oncomine Precision Assay (OPA) panel to characterize oncology biospecimens
TSO 500 Selected Biomarkers
Lung | Melanoma | Colon | Ovary | Breast | Gastric | Bladder | Myeloid | Pan-cancer |
---|---|---|---|---|---|---|---|---|
AKT1 |
BRAF |
AKT1 |
BRAF |
AKT1 |
BRAF |
MSH5 |
ALBL1 |
MSI |
ALK |
CTNNB1 |
BRAF |
BRCA1 |
AR |
KIT |
PMS2 |
ASXL1 |
NTRK |
BRAF |
GNA11 |
HRAS |
BRCA2 |
BRCA1 |
KRAS |
TSC1 |
CALR |
|
DDR2 |
GNAQ |
KRAS |
KRAS |
BRCA2 |
MET |
CESPA |
||
EGFR |
KIT |
MET |
PDGFRA |
ERBB2 |
MLH1 |
ETV6 |
||
ERBB2 |
MAP2K1 |
MLH1 |
FOXL2 |
FGFR1 |
PDGFRA |
EZH2 |
||
FGFR1 |
NF1 |
MSH2 |
TP53 |
FGFR2 |
TP53 |
FLT3 |
||
FGFR3 |
NRAS |
MSH5 |
PIK3CA |
GATA3 |
||||
KRAS |
PDGFRA |
NRAS |
PTEN |
IDH1 |
||||
MAP2K1 |
PIK3CA |
PIK3CA |
IDH2 |
|||||
MET |
PTEN |
PMS2 |
JAK2 |
|||||
NRAS |
TP53 |
PTEN |
KIT |
|||||
PIK3CA |
SMAD4 |
MPL |
||||||
PTEN |
TP53 |
NPM1 |
||||||
RET |
RUNX1 |
|||||||
TP53 |
SF3B1 |
|||||||
TMB |
SRSF2 |
|||||||
TP53 |
OPA Biomarkers
DNA Hotspots
AKT1 | ESR1 | MAP2K2 |
---|---|---|
AKT2 |
FGFR1 |
MET |
AKT3 |
FGFR2 |
MTOR |
ALK |
FGFR3 |
NRAS |
AR |
FGFR4 |
NRTK1 |
ARAF |
FTL3 |
NTRK2 |
BRAF |
GNA11 |
NTRK3 |
CDK4 |
GNAQ |
PDGFRA |
CDKN2A |
GNAS |
PIK3CA |
CHEK2 |
HRAS |
PTEN |
CTNNB1 |
IDH1 |
RAF1 |
EGFR |
IDH2 |
RET |
ERBB2 |
KIT |
ROS1 |
ERBB3 |
KRAS |
SMO |
ERBB4 |
MAP2K1 |
TP53 |
CNV
AKT1 |
---|
AKT2 |
AKT3 |
ALK |
AR |
ARAF |
BRAF |
CDK4 |
CDKN2A |
CHEK2 |
CTNNB1 |
EGFR |
ERBB2 |
ERBB3 |
ERBB4 |
Inter-genetic fusions
ALK | NTRK2 |
---|---|
BRAF |
NTRK3 |
ESR1 |
NUTM1 |
FGFR1 |
RET |
FGFR2 |
ROS1 |
FGRF3 |
RSPO2 |
MET |
RSPO3 |
NRG1 |
- |
NTRK1 |
- |
Intra-genetic fusions
AR |
---|
EGFR |
MET |
Explore Precision’s other available biospecimens
